However, we find that the variances in RSK2 expression in normal brain tissue and in the three human glioma tissue datasets are relatively small and comparable in size, suggesting that RSK2 expression variations also occur in glioma. The gene discussed is RPS6KA3; the disease is central nervous system cancer.